Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a passive-surveillance study that will accrue subjects for surveillance. For each accrued subject, surveillance for outcomes will continue for six months following the first dose. If a second dose is given within that time, then surveillance will be continued for six months following the second dose. Observational Objective: * To describe and characterize adverse events occurring after vaccination with Menactra vaccine.
Epistemonikos ID: 93ff7ba0501cbe151f7a1314a1b6878d5d304188
First added on: May 11, 2024